P21(ras) in carcinogenesis

Pathology Research and Practice

Volumn 192, Issue 7, 1996, Pages 658-668

  De Vries, J E ^a   Ten Kate, J ^b   Bosman, F T ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b De Wever Hospital ^*  (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Apoptosis; Carcinogenesis; Cell cycle regulation; p21(ras) on oncogenes

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN P21; RAS PROTEIN; CARCINOGEN; HRAS PROTEIN, HUMAN;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL DEATH; CELL DIVISION; CELL GROWTH; ETIOLOGY; GENE EXPRESSION; HUMAN; MORPHOLOGY; NUTRITIONAL REQUIREMENT; PROTEIN INTERACTION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL TRANSFORMATION; DNA DAMAGE; DRUG EFFECT; GENETICS;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; HUMANS; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 0029658248     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80087-2     Document Type: Article

References (139)

1. Angel P, Karin M (1991 ) The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157
2. Arends MJ, McGregor AH, Toft NJ, Brown EJH, Wyllie AH (1993) Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer 68: 1127-1133
3. Arends MJ, McGregor AH, Wyllie AH (1994) Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am J Pathol 144: 1045-1057
4. Aronheim A, Engelberg D, Li N, Al-Alawi N, Schlessinger J, Karin M (1994) Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78: 949-961
5. Barbacid M (1987) ras genes. Annu Rev Biochem 56: 779-827
6. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356: 713-715
7. Bernards A (1995) Neurofibromatosis type 1 and Ras-mediated signaling: Filling in the GAPs. Biochim Biophys Acta 1242: 43-59
8. Boguski MS, McCormick F (1993) Proteins regulating Ras and its relatives. Nature 366: 643-654
9. Bos JL (1989) Ras oncogenes in human cancer: A review. Cancer Res 49: 4682-4689
10. Bourne HR, Sanders DA, McCormick F (1991) The GTPase superfamily: conserved structure and molecular mechanism. Nature 349: 117-127
11. Burgering BMT, Bos JL (1995) Regulation of Ras-mediated signalling: more than one way to skin a cat. TIBS 20: 18-22
12. Burgering MT, Coffer PJ (1995) Protein kinase B (c-Akt) in phosphatidyhnositol-3-OH kinase signal transduktion. Nature 376: 599-602
13. Cantley L, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S (1991) Oncogenes and signal transduction. Cell 64: 281-302
14. Chang J-H, Gill S, Settleman J, Parsons SJ (1995) c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation. J Cell Biol 130: 355-368
15. Chant J, Stowers L (1995) GTPase cascades choreographing cellular behavior: Movement, morphogenesis, and more. Cell 81: 1-4
16. Cherniack AD, Klarlund JK, Czech MP (1994) Phosphorylation of the Ras nucleotide exchange factor Son of sevenless by Mitogen-activated protein kinase. J Biol Chem 269: 4717-4720
17. Chuang E, Barnard D, Hettich L, Zhang X-F, Avruch J, Marshall MS (1994) Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues. Mol Cell Biol 14: 5318-5325
18. S6K activation mediated by phosphatidylinositol-3-OH kinase. Nature 370: 71-75
19. Claesson-Welsh L (1994) Platelet-derived growth factor receptor signals. J Biol Chem 269: 32023-32026
20. Cook SJ, McCormick F (1993) Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069-1072
21. Coso OA, Ciariello M, Yu Y-C, Teramoto H, Crespo P, Xu N, Miki T, Gutkind JS (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81: 1137-1146
22. Cowley S, Paterson H, Kemp P, Marshall CJ (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852
23. Crews CM, Alessandrini A, Erikson RL (1992) The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 258: 478-480
24. Daksis JI, Lu RY, Facchini LM, Marhin WW, Penn LJZ (1994) Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 9: 3635-3645
25. Daum G, Eisenmann-Tappe I, Fries H-W, Troppmair J, Rapp UR (1994) The ins and outs of Raf kinases. TIBS 19: 474-480
26. Davis RJ (1993) The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556
27. Denko NC, Giaccia AJ, Stringer JR, Stambrook PJ (1994) The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc Natl Acad Sci USA 91: 5124-5128
28. Downward J (1994) The GRB2/Sem-5 adaptor protein. FEBS Letters 338: 113-117
29. Duchesne M, Schweighoffer F, Parker F, Clerc F, Frobert Y, Thang MN, Tocque B (1993) Identification of the SH3 domain of GAP as an essential sequence for Ras-GAP-mediated signaling. Science 259: 525-528
30. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA (1993) Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363: 45-51
31. Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro I, Hager G, Greenberg AH (1987) Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 7: 830-837
32. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
33. Evan GI, Littlewood TD (1993) The role of c-myc in cell growth. Curr Opin Genet Dev 3: 44-49
34. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128
35. Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, Gross RW, Williams LT (1994) Activation of Raf-1 by 14-3-3 proteins. Nature 371: 612-614
36. Feig LA, Cooper GM (1988) Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 8: 3235-3243
37. Feramisco JR, Gross M, Kamata T, Rosenberg M, Sweet RW (1984) Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38: 109-117
38. Fernandez-Sarabla MJ, Bisschoff JR (1993) Bcl-2 associates with the ras-related protein R-ras p23. Nature 366: 274-275
39. Filmus J, Robles AI, Shi W, Wong MJ, Colombo LL, Conti CJ (1994) Induction of cyclin D1 overexpression by activated ras. Oncogene 9: 3627-3633
40. Flier JS, Mueckler MM, Usher P, Lodish HF (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235: 1492-1495
41. Franke TF, Yang S-I, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN (1995) The protein kinase encoded by the akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol-3 kinase. Cell 81: 727-736
42. Gould GW, Holman GD (1993) The glucose transporter family: Structure, function, and tissue-specific expression. Biochem J 295: 329-341
43. Hafner S, Adler HS, Mischak H, Janosch P, Heidecker G, Wolfman A, Pippig S, Lohse M, Ueffing M, Kolch W (1994) Mechanism of inhibition of Raf-1 by protein kinase A. Mol Cell Biol 14: 6696-6703
44. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54: 2095-2097
45. Harlan JE, Hajduk PJ, Yoon NS, Fesik SW (1994) Pleckstrin homology domains bind to phosphatidylinositol-4,5-biphosphate. Nature 371: 168-170
46. Hartwell L (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71: 543-546
47. Hatanaka M (1974) Transport of sugars in tumor cell membranes. Biochim Biophys Acta 355: 77-104
48. Hausdorff SF, Frangioni JV, Birnbaum MJ (1994) Role of p21 ras in insulin-stimulated glucose transport in 3T3-L1 adipocytes. J Biol Chem 269: 21391-21394
49. Heidecker G, Huleihel M, Cleveland JL, Kolch W, Beck TW, Lloyd P, Pawson T, Rapp UR (1990) Mutational activation of c-raf-1 and definition of the transforming sequence. Mol Cell Biol 10: 2503-2512
50. Hermeking H, Eick D (1994) Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091-2093
51. Hickman JA (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11: 121-139
52. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA (1994) Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91: 709-713
53. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993-1006
54. Hu C, Pang S, Kong X, Velleca M, Lawrence Jr JC (1994) Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors. Proc Natl Acad Sci USA 91: 3730-3734
55. Huang W, Allessandrini A, Crews CM, Erikson RL (1993) Raf-1 forms a stable complex with MEK1 and activates MEK1 by serine phosphorylation. Proc Natl Acad Sci USA 90: 10947-10951
56. Hunter T, Pines J (1994) Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582
57. Ichikawa T, Schalken JA, Ichikawa Y, Steinberg GD, Isaacs JT (1991) H-ras expression, genetic instability, and acquisition of metastatic ability by rat prostatic cancer cells following v-H-ras oncogene transaction. Prostate 18: 163-172
58. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB (1993) Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8: 3447-3457
59. Kaplan DR, Morrison DK, Wong G, McCormick F, Williams LT (1990) PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell 61: 125-133
60. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311
61. Kelekar A, Cole MD (1987) Immortalization by c-myc, H-ras, and Ela oncogenes induces differential cellular gene expression and growth factor responses. Mol Cell Biol 7: 3899-3907
62. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeiler G, Marme D, Rapp UR (1993) Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364: 249-252
63. Kozma L, Baltensperger K, Klarlund J, Porras A, Santos E, Czech MP (1993) The ras signaling pathway mimics insulin action on glucose transporter facilitation. Proc Natl Acad Sci USA 90: 4460-4464
64. Leevers SJ, Paterson HF, Marshall CJ (1994) Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369: 411-414
65. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D (1994) The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69: 409-416
66. Li S, Janosch P, Tanji M, Rosenfeld GC, Waymire JC, Mischak H, Kolch W, Sedivy JM (1995) Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins. The EMBO Journal 14: 685-696
67. LoebLA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 57: 3075-3079
68. Lowe SW, Ruley HE, Jacks T (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967
69. Marais R, Light Y, Paterson HE, Marshall CJ (1995) Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. The EMBO Journal 14: 3136-3145
70. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185
71. ras. TIBS 18: 250-254
72. Martin GA, Yatani A, Clark R, Conroy L, Polakis P, Brown AM, McCormick F (1992) GAP domains responsible for Ras p21-dependent inhibition of muscarinic atrial K+ channel currents. Science 255: 192-194
73. Marx J (1994) How cells cycle towards cancer. Science 263: 319-321
74. McGlade J, Brunkhorst B, Anderson D, Mbamalu G, Settleman J, Dedhar S, Rozakis-Adcock M, Chen LB, Pawson T (1993) The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion. The EMBO Journal 12: 3073-3081
75. Medema RH, de-Laat WL, Martin GA, McCormick F, Bos JL (1992) GTPase-activating protein SH2-SH3 domains induce gene expression in a Ras-dependent fashion. Mol Cell Biol 12: 3425-3430
76. Merral NW, Plevin R, Gould GW (1993) Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signalling 5: 667-675
77. Milne DM, Campbell DG, Caudwell FB, Meek DW (1994) Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases. J Biol Chem 269: 9253-9260
78. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805
79. Morgan DO (1995) Principles of CDK regulation. Nature 374: 131-134
80. Mulcahy LS, Smith MR, Stacey DW (1985) Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313: 241-243
81. Nevins JR (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-429
82. Newman CM, Magee AI (1993) Posttranslational processing of the ras superfamily of small GTP-binding proteins. Biochim Biophys Acta 1155: 79-96
83. Noves CD, Hawkins P, Stephens L, Hall A (1995) Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J Cell Sci 108: 225-233
84. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J Biol Chem 269: 3568-3573
85. Pause A, Belsham GJ, Gingras A-C, Donze O, Lin T-A, Lawrence JC, Sonenberg N (1994) Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371: 762-767
86. Pawson T (1995) Protein modules and signalling networks. Nature 373: 573-580
87. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grignani F, Pawson T, Pelicci PG (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70: 93-104
88. Peppelenbosch MP, Qiu R-G, de Vries-Smits AMM, Tertooien LGJ, de Laat SW, McCormick F, Hall A, Symons MH, Bos JL (1995) Rac mediates growth factor-induced arachidonic acid release. Cell 81: 849-856
89. 88a Peter M, Herskowitz I (1994) Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79: 181-184
90. ras in receptor tyrosine kinase signalling. Biochim Biophys Acta 1198: 131-147
91. rassignaling. Oncogene 8: 2773-2780
92. Proud CG (1994) Turned on by insulin. Nature 371: 747-748
93. Pulciani S, Santos E, Lauver AV, Long LK, Robbins KC, Barbacid M (1982) Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells. Proc Natl Acad Sci USA 79: 2845-2849
94. Pusztai L, Lewis CE, Lorenzen J, McGee JO'D (1993) Growth factors: Regulation of normal and neoplastic growth. J Pathol 169: 191-201
95. Qiu R-G, Chen J, Kim D, McCormick F, Symons M (1995) An essential role for Rac in Ras transformation. Nature 374: 457-459
96. Quax PHA, van Muijen GNP, Weening-Verhoeff EJD, Lund LR, Dano K, Ruiter DJ, Verheijen JH (1991) Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase mediated matrix degradation. J Cell Biol 115: 191-199
97. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 224: 1-6
98. Ren R, Mayer BJ, Cicchetti P, Baltimore D (1993) Identification of a ten-amino acid Proline-rich SH3 binding site. Science 259: 1157-1161
99. Reszka AA, Seger R, Diltz CD, Krebs EG, Fischer EH (1995) Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 92: 8881-8885
100. ras activation in the metabolic signaling by insulin. J Biol Chem 270: 2036-2040
101. Rey I, Taylor-Harris P, van Erp H, Hall A (1994) R-ras interacts with rasGAP, neurofibromin and c-Raf but does not regulate cell growth or differentiation. Oncogene 9: 685-692
102. Richard S, Yu D, Blumer KJ, Hausladen D, Olszowy MW, Connelly PA, Shaw AS (1995) Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma 1. Mol Cell Biol 25: 186-197
103. Ridley AJ, Hall A (1992) The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399
104. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A (1992) The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70: 401-410
105. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527-532
106. Rogge RD, Karlovich CA, Banerjee U (1991) Genetic dissection of a neurodevelopmental pathway: Son of sevenless functions downstream of the sevenless and EGF receptor tyrosine kinases. Cell 64: 39-48
107. Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV (1993) Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 13: 7358-7363
108. Rossomando AJ, Payne DM, Weber MJ, Sturgill TW (1989) Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase. Proc Natl Acad Sci USA 86: 6940-6943
109. Rozakis-Adcock M, McGlade J, Mbamalu G, Pellici G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pellici PG, Schlessinger J, Pawson T (1992) Association of the Shc and Grb2/Sem-5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360: 689-692
110. Serth J, Lautwein A, Frech M, Wittinghofer A, Pingoud A (1991) The inhibition of the GTPase activating protein-Ha-ras interaction by acidic lipids is due to physical association of the C-terminal domain of the GTPase activating protein with micellar structures. The EMBO Journal 10: 1325-1330
111. Settleman J, Narasimhan V, Foster LC, Weinberg RA (1992) Molecular cloning of cDNAs encoding the GAP-associated protein p190: implications for a signaling pathway from ras to the nucleus. Cell 69: 539-549
112. Sherr CJ (1994) G1 phase progression: Cycling on cue. Cell 79: 551-555
113. Sherr CJ (1995) D-type cyclins. TIBS 20: 187-190
114. Shih C, Padhy LC, Murray M, Weinberg RA (1981) Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261-264
115. ras1 activation and binds to sevenless and sos proteins in vitro. Cell 73: 169-177
116. Slebos RJC, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hedrick L, Kastan MB, Cho KR (1994) p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci USA 91: 5320-5324
117. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767-778
118. Spaargaren M, Martin GA, McCormick F, Fernandez-Sarabia, Bischoff JR (1994) The Ras-related protein R-ras interacts directly with Raf-1 in a GTP-dependent manner. Biochem J 300: 303-307
119. Stacey DW, Kung H-F (1984) Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature 310: 508-511
120. Trahey M, McCormick F (1987) A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238: 542-545
121. Ui M, Okada T, Hazeki K, Hazeki O (1995) Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. TIBS 20: 303-307
122. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212
123. Valius M, Kazlauskas A (1993) Phospholipase C-gamma1 and phosphatidylinoskol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73: 321-334
124. Vogel US, Dixon RA, Schaber MD, Diehl RE, Marshall MS, Scolnick EM, Sigal IS, Gibbs JB (1988) Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 335: 90-93
125. Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70: 523-526
126. Vojtek AB, Hollenberg SM, Cooper JA (1993) Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74: 205-214
127. Vries JE, Kornips FHAC, Marx P, Bosman FT, Geraedts JPM, ten Kate J (1993) Transfected c-Ha-ras oncogene enhances karyorypic instability and integrates predominantly in aberrant chromosomes. Cancer Genet Cytogenet 65: 35-43
128. Wang H-G, Millan JA, Cox AD, Der CJ, Rapp UR, Beck T, Zha H, Reed JC (1995) R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism. J Cell Biol 129: 1103-1114
129. Wang H-G, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, Tanaka S, Hovey L, Troppmair J, Rapp UR, Reed JC (1994) Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 9: 2751-2756
130. Warns PH, Viclana PR, Downward J (1993) Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364: 352-355
131. Waters SB, Holt KH, Ross SE, Syu L-J, Guan K-L, Saltiel AR, Koretzky GA, Pessin JE (1995) Desensitization of Ras activation by a feedback disassociation of the Sos-Grb2 complex. J Biol Chem 270: 20883-20886
132. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330
133. Weng Q-P, Andrabi K, Klippel A, Kozlowski MT, Williams LT, Avruch J (1995) Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proc Natl Acad Sci USA 92: 5744-5748
134. White MF, Kahn CR (1994) The insulin signaling system. J Biol Chem 269: 1-4
135. Wong G, Muller O, Clark R, Conroy L, Moran MF, Polakis P, McCormick F (1992) Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62. Cell 69: 551-558
136. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065-1069
137. Wymann M, Arcaro A (1994) Platelet-derived growth factor-induced phosphatidylinositol 3-kinase activation mediates actin rearrangements in fibroblasts. Biochem J 298: 517-520
138. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R et al. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599-608
139. Zhang X-F, Settleman J, Kyriakis JM, Takeuchi-Suzuki E, Elledge SJ, Marshall MS, Bruder JT, Rapp UR, Avruch J (1993) Normal and oncogenic p21 ras proteins bind to the amino-terminal domain of c-Raf-1. Nature 364: 308-313